CanSino Biologics, Inc. (CASBF)
4.90
+0.25
(+5.32%)
USD |
OTCM |
Oct 06, 16:00
CanSino Biologics Gross Profit Margin (Quarterly) : 67.99% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 67.99% |
| March 31, 2026 | 68.26% |
| December 31, 2025 | 64.97% |
| September 30, 2025 | 70.25% |
| June 30, 2025 | 72.53% |
| March 31, 2025 | 64.94% |
| December 31, 2024 | 69.08% |
| September 30, 2024 | 68.93% |
| June 30, 2024 | 60.05% |
| March 31, 2024 | 32.99% |
| December 31, 2023 | 35.56% |
| September 30, 2023 | 22.83% |
| June 30, 2023 | |
| March 31, 2023 | 9.81% |
| December 31, 2022 | 39.37% |
| Date | Value |
|---|---|
| September 30, 2022 | -1.30% |
| June 30, 2022 | 33.96% |
| March 31, 2022 | 66.74% |
| December 31, 2021 | 78.37% |
| September 30, 2021 | 57.60% |
| June 30, 2021 | 74.39% |
| March 31, 2021 | 50.39% |
| December 31, 2020 | -17.11% |
| September 30, 2020 | -436.9% |
| June 30, 2020 | |
| March 31, 2020 | 0.00% |
| December 31, 2019 | -3.08K% |
| September 30, 2019 | -46.96K% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 0.82% |
| Return on Assets | 0.56% |
| Return on Invested Capital | 0.64% |
| Profit Margin (Quarterly) | 11.04% |
| Operating Margin (Quarterly) | 3.26% |
| Return on Net Operating Assets | 0.97% |